Brian BradfieldTop StoriesMolecular ImagingPET improves treatment planning for pituitary tumorsGa-68 DOTATATE PET altered radiation treatment volumes by nearly 20% compared with MRI alone.AIReplacing radiologists doesn’t remove risk -- it moves it to patientsEconomicsRadiology researchers weigh in on the impact of the political climateAIChildren ‘almost invisible’ in public imaging datasetsSponsor ContentRadiology is Under Pressure
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&fit=crop&h=400&q=70&w=600)
